Table 3 Microcirculatory evaluation (NVC) and vasoreactivity analysis (VOP)

NVC FCD (number of capillaries/mm²)

13.6 [12.6-14.9]

12.8 [11.9-13.7]

0.100

AFD (μm)

8.5 [6.1-11.2]

15.4 [13.7-16.3]*

< 0.01

APD (μm)

8.7 [7.1-10.7]

15.3 [13.6-17.0]*

< 0.01

EFD (μm)

8.7 [7.2-12.0]

14.9 [14.3-16.2]*

< 0.01

RBCVbasal

0.24 [0.22-0.28]

0.29 [0.29-0.30]*

< 0.05

RBCV_max

0.35 [0.33-0.39]

0.35 [0.34-0.36]

0.616

RBCV_max/RBCV_bas

1.35 [1.21-1.79]

1.23 [1.17-1.26]*

< 0.05

Time to reach RBCV_max/RBCV_bas (s)

5 [4-6]

4 [4-6]

0.408

VOP

% Hyper

606 [508-744]

316 [256-465]*

< 0.001

% Nitro

208 [122-257]

187 [130-202]

0.530